Clinical Presentations

In this special Homerun Slides presentation, details of the CANTATA-D2 study are reviewed comparing the effects and benefits of the SGLT2 inhibitors and DPP-4 inhibitors…. To download in PowerPoint (.ppt) format: SGLT2 Inhibitors for Treatment of Type 2 Diabetes See more SGLT-2 Resources

  In this week’s Homerun Slides, we discuss the Health Benefits of Modest Weight Loss; review some of the causes of the modern obesity crisis; and go over some of the Medical Consequences of Obesity….

In this week’s Homerun Slides, Dr. Stanley Schwartz guides us through the basic physiology of modern obesity and the "toxic environment" of abundant cheap food and little exercise we all seem to live in….

  This week, we begin a new Homerun Slides series from Dr. Stanley Schwartz on obesity. This first set in the series includes an overview of the current situation in the U.S. as well as a discussion of the term "metabolically health obese" and why Dr. Schwartz thinks this is …

  In this week’s Homerun Slides, Dr. Stanley Schwartz goes over some of the accepted algorithms for diabetes control but suggests some novel changes including the addition of GLP-1’s closer to diagnosis. He also discusses studies that have combined SGLT2 inhibitor therapy with incretins…

  This week’s Homerun Slides from Dr. Stanley Schwartz cover topics including Non-insulin Therapies and the Recommended Goals for the ABC’s of Diabetes Care (A1c, BP, and Cholesterol)….

In this week’s Homerun Slides from Dr. Stanley Schwartz, we continue our discussion of medications, including the SGLT2 inhibitor canagliflozin and the central dopamine agonist bromocriptine. We then begin to delve into therapy for type 2 diabetes, targets for glycemic control, and targeting postprandial glucose….

  In this week’s Homerun Slides, Dr. Stanley Schwartz reviews some of the treatments patients have received in-hospital when under physical stress and compares the results of different treatment regimens….

  In this week’s series of Homerun Slides, we continue with our update on the current state of type 2 therapy with Dr. Stanley Schwartz. Topics include: Potential mechanisms of reducing CV outcomes with DPP-IV inhibitors; exenatide and CV outcomes; and Incretins in Type 2 Patients….

  In this week’s Homerun Slides, we continue our series from Dr. Stanley Schwartz, with a focus on some of the treatments drugs including metformin, pioglitazone, and the glp-1 agonists….